Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | FP-1305 |
| Trade Name | |
| Synonyms | FP1305|FP 1305|Clevegen|Bexmarilimab |
| Drug Descriptions |
FP-1305 is a humanized IgG4 antibody that targets the scavenger receptor Clever-1 on tumor-associated macrophages, which may lead to immune cell activation and tumor growth inhibition (PMID: 34078651). |
| DrugClasses | |
| CAS Registry Number | 2259301-27-2 |
| NCIT ID | C159536 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Azacitidine + FP-1305 | Azacitidine FP-1305 | 0 | 1 |
| Azacitidine + FP-1305 + Venetoclax | Azacitidine FP-1305 Venetoclax | 0 | 1 |
| FP-1305 | FP-1305 | 0 | 1 |
| FP-1305 + Pembrolizumab | FP-1305 Pembrolizumab | 0 | 1 |